Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$498M |
| 2 |
Micron Technology
MU
|
+$374M |
| 3 |
Amazon
AMZN
|
+$356M |
| 4 |
Accenture
ACN
|
+$318M |
| 5 |
Advanced Micro Devices
AMD
|
+$301M |
Top Sells
| 1 |
Apple
AAPL
|
+$684M |
| 2 |
Meta Platforms (Facebook)
META
|
+$630M |
| 3 |
Tesla
TSLA
|
+$595M |
| 4 |
Chevron
CVX
|
+$497M |
| 5 |
Shopify
SHOP
|
+$439M |
Sector Composition
| 1 | Healthcare | 19.38% |
| 2 | Technology | 18.55% |
| 3 | Consumer Staples | 10.17% |
| 4 | Consumer Discretionary | 9.68% |
| 5 | Financials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3626
Imunon
IMNN
$14.1M
| $90K | ﹤0.01% |
4,103
+92
| +2% | +$2.02K |
|
3627
Lipocine
LPCN
$16.3M
| $90K | ﹤0.01% |
11,729
+6,964
| +146% | +$53.4K |
|
3628
Moleculin Biotech
MBRX
$11.5M
| $90K | ﹤0.01% |
5,633
-240
| -4% | -$3.84K |
|
3629
SPAR Group
SGRP
$27.7M
| $90K | ﹤0.01% |
62,000
-23,100
| -27% | -$33.5K |
|
|
QXO
3630
QXO Inc
QXO
$14.5B
| $90K | ﹤0.01% |
3,991
+316
| +9% | +$7.13K |
|
|
NIXX
3631
Nixxy, Inc. Common Stock
NIXX
$32.5M
| $90K | ﹤0.01% |
4,913
-1,300
| -21% | -$23.8K |
|
|
SUNW
3632
DELISTED
Sunworks, Inc.
SUNW
| $90K | ﹤0.01% |
32,228
-722,172
| -96% | -$2.02M |
|
3633
Eledon Pharmaceuticals
ELDN
$155M
| $88K | ﹤0.01% |
31,873
-300
| -0.9% | -$828 |
|
3634
Rush Street Interactive
RSI
$2.01B
| $88K | ﹤0.01% |
23,800
+13,200
| +125% | +$48.8K |
|
|
AUMN
3635
DELISTED
Golden Minerals Company
AUMN
| $88K | ﹤0.01% |
13,672
+4,524
| +49% | +$29.1K |
|
|
RIBT
3636
DELISTED
RiceBran Technologies
RIBT
| $88K | ﹤0.01% |
48,968
-3,838
| -7% | -$6.9K |
|
3637
Arbutus Biopharma
ABUS
$886M
| $87K | ﹤0.01% |
+45,660
| New | +$87K |
|
3638
Vista Gold
VGZ
$195M
| $87K | ﹤0.01% |
165,541
-71,538
| -30% | -$37.6K |
|
3639
Perspective Therapeutics
CATX
$240M
| $86K | ﹤0.01% |
37,213
-496
| -1% | -$1.15K |
|
3640
ENDRA Life Sciences
NDRA
$3.2M
| $86K | ﹤0.01% |
8
-8
| -50% | -$86K |
|
3641
Predictive Oncology
POAI
$10.3M
| $86K | ﹤0.01% |
11,923
-8,332
| -41% | -$60.1K |
|
3642
Recon Technology
RCON
$64.6M
| $86K | ﹤0.01% |
8,417
-227
| -3% | -$2.32K |
|
3643
Paranovus Entertainment Technology
PAVS
$57.2M
| $85K | ﹤0.01% |
27,581
-11,338
| -29% | -$34.9K |
|
|
BFI
3644
DELISTED
BurgerFi International, Inc. Common Stock
BFI
| $85K | ﹤0.01% |
32,720
-89,180
| -73% | -$232K |
|
|
IMPL
3645
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $85K | ﹤0.01% |
17,400
+200
| +1% | +$977 |
|
3646
Farmmi
FAMI
$2.47M
| $84K | ﹤0.01% |
1,570
-2,606
| -62% | -$139K |
|
3647
Helius Medical Technologies
HSDT
$7.38M
| $84K | ﹤0.01% |
8
+7
| +700% | +$73.5K |
|
|
ETHZ
3648
ETHZilla Corporation Common Stock
ETHZ
$409M
| $83K | ﹤0.01% |
327
+24
| +8% | +$6.09K |
|
3649
Creative Realities
CREX
$24.1M
| $83K | ﹤0.01% |
46,333
+1,833
| +4% | +$3.28K |
|
3650
Werewolf Therapeutics
HOWL
$64.5M
| $83K | ﹤0.01% |
18,300
+1,500
| +9% | +$6.8K |
|